Polomar Health Financials
This page shows Polomar Health (PMHS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Polomar Health has an operating margin of -2209.1%, meaning the company retains $-2209 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -1053.5% the prior year.
Polomar Health's revenue surged 40.6% year-over-year to $59K, reflecting rapid business expansion. This strong growth earns a score of 100/100.
Polomar Health carries a low D/E ratio of 0.16, meaning only $0.16 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.
Polomar Health's current ratio of 0.06 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 0/100, which could limit financial flexibility.
While Polomar Health generated -$1.0M in operating cash flow, capex of $91K consumed most of it, leaving -$1.1M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Polomar Health generates a -15.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100.
Polomar Health passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, Polomar Health generates $0.76 in operating cash flow (-$1.0M OCF vs -$1.3M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Polomar Health earns $-31.1 in operating income for every $1 of interest expense (-$1.3M vs $42K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Polomar Health generated $59K in revenue in fiscal year 2024. This represents an increase of 40.6% from the prior year.
Polomar Health's EBITDA was -$1.0M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 138.2% from the prior year.
Polomar Health reported -$1.3M in net income in fiscal year 2024. This represents a decrease of 128.1% from the prior year.
Polomar Health earned $-0.05 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 150.0% from the prior year.
Cash & Balance Sheet
Polomar Health generated -$1.1M in free cash flow in fiscal year 2024, representing cash available after capex.
Polomar Health held $6K in cash against $0 in long-term debt as of fiscal year 2024.
Polomar Health had 28M shares outstanding in fiscal year 2024. This represents an increase of 0.0% from the prior year.
Margins & Returns
Polomar Health's gross margin was 52.5% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 37.2 percentage points from the prior year.
Polomar Health's operating margin was -2209.1% in fiscal year 2024, reflecting core business profitability. This is down 1155.6 percentage points from the prior year.
Polomar Health's net profit margin was -2280.3% in fiscal year 2024, showing the share of revenue converted to profit. This is down 875.0 percentage points from the prior year.
Polomar Health's ROE was -15.6% in fiscal year 2024, measuring profit generated per dollar of shareholder equity.
Capital Allocation
Polomar Health invested $91K in capex in fiscal year 2024, funding long-term assets and infrastructure.
PMHS Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6K+12.7% | $5K+20.4% | $5K-78.2% | $21K+111.9% | $10K-32.1% | $14K+6.5% | $14K | N/A |
| Cost of Revenue | $2K+12.3% | $2K+20.4% | $1K-88.5% | $12K+1098.0% | $985-76.8% | $4K-61.1% | $11K | N/A |
| Gross Profit | $4K+12.8% | $4K+20.4% | $3K-64.9% | $9K+2.3% | $9K-13.6% | $10K+278.0% | $3K | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $619K+11.2% | $557K+39.6% | $399K-42.4% | $692K+169.9% | $256K+37.1% | $187K+25.2% | $149K | N/A |
| Operating Income | -$629K-11.6% | -$563K-35.6% | -$415K+39.7% | -$689K-165.9% | -$259K-35.9% | -$191K-18.9% | -$160K | N/A |
| Interest Expense | $21K-50.4% | $42K+1.9% | $41K | N/A | $12K | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$650K-7.3% | -$606K-32.6% | -$457K+36.4% | -$719K-164.9% | -$271K-42.3% | -$191K-18.9% | -$160K-25.8% | -$128K |
| EPS (Diluted) | $-0.020.0% | $-0.020.0% | $-0.02 | N/A | $-0.01 | $-0.010.0% | $-0.01 | N/A |
PMHS Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.3M-1.7% | $9.4M-3.8% | $9.8M-1.4% | $10.0M-3.3% | $10.3M+3501704.1% | $294+20.5% | $244-99.8% | $107K |
| Current Assets | $198K+112.4% | $93K-53.8% | $201K+161.9% | $77K-50.8% | $156K+52996.9% | $294+20.5% | $244-98.0% | $12K |
| Cash & Equivalents | $39K+730.6% | $5K-96.4% | $129K+1989.0% | $6K-61.8% | $16K+5410.9% | $294+20.5% | $244+8.9% | $224 |
| Inventory | $159K+113.5% | $74K+6.2% | $70K+1.8% | $69K-50.8% | $140K | N/A | N/A | $3K |
| Accounts Receivable | N/A | $2K0.0% | $2K0.0% | $2K | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | $250K | N/A | N/A | N/A |
| Total Liabilities | $1.5M+45.0% | $1.0M-37.8% | $1.7M+23.2% | $1.4M+38.4% | $977K+146.8% | $396K+93.0% | $205K+35.4% | $152K |
| Current Liabilities | $1.5M+45.0% | $1.0M-37.5% | $1.7M+24.1% | $1.3M+40.3% | $954K+826.2% | $103K+24.4% | $83K-19.2% | $102K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $7.8M-7.5% | $8.4M+3.1% | $8.1M-5.3% | $8.6M-7.7% | $9.3M+2454.5% | -$396K-93.0% | -$205K-360.3% | -$45K |
| Retained Earnings | -$4.6M-16.4% | -$4.0M-18.0% | -$3.4M-15.7% | -$2.9M-32.8% | -$2.2M-47.4% | -$1.5M-1.4% | -$1.5M+6.5% | -$1.6M |
PMHS Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$353K-87.8% | -$188K-312.0% | -$46K+85.5% | -$315K-7.8% | -$292K-17.8% | -$248K-50.5% | -$165K+25.1% | -$220K |
| Capital Expenditures | N/A | N/A | N/A | $0-100.0% | $11K-72.5% | $39K-6.5% | $41K | N/A |
| Free Cash Flow | N/A | N/A | N/A | -$315K-4.0% | -$303K-5.6% | -$287K-39.0% | -$206K | N/A |
| Investing Cash Flow | N/A | N/A | N/A | $0+100.0% | -$11K+72.5% | -$39K+6.5% | -$41K | N/A |
| Financing Cash Flow | $387K+512.8% | $63K-62.6% | $169K-44.7% | $305K+2.0% | $299K+7.4% | $279K+23.6% | $225K+273.3% | $60K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
PMHS Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.1%+0.1pp | 70.0%0.0pp | 70.1%+26.6pp | 43.5%-46.5pp | 90.0%+19.2pp | 70.8%+50.8pp | 19.9% | N/A |
| Operating Margin | -10203.0%+95.6pp | -10298.6%-1152.7pp | -9145.9%-5844.0pp | -3301.9%-670.5pp | -2631.5%-1315.5pp | -1315.9%-136.9pp | -1179.0% | N/A |
| Net Margin | -10543.2%+527.5pp | -11070.6%-1012.2pp | -10058.5%-6614.3pp | -3444.1%-689.2pp | -2754.9%-1439.0pp | -1315.9%-136.9pp | -1179.0% | N/A |
| Return on Equity | -8.4%-1.2pp | -7.2%-1.6pp | -5.6%+2.7pp | -8.4%-5.4pp | -2.9% | N/A | N/A | N/A |
| Return on Assets | -7.0%-0.6pp | -6.4%-1.8pp | -4.7%+2.6pp | -7.2%-4.6pp | -2.6%+64875.6pp | -64878.2%+887.3pp | -65765.6%-65646.4pp | -119.1% |
| Current Ratio | 0.13+0.0 | 0.09-0.0 | 0.12+0.1 | 0.06-0.1 | 0.16+0.2 | 0.000.0 | 0.00-0.1 | 0.12 |
| Debt-to-Equity | 0.19+0.1 | 0.12-0.1 | 0.20+0.0 | 0.16+0.1 | 0.10+1.1 | -1.000.0 | -1.00+2.4 | -3.40 |
| FCF Margin | N/A | N/A | N/A | -1509.3%+1564.9pp | -3074.2%-1096.4pp | -1977.8%-462.6pp | -1515.2% | N/A |
Note: The current ratio is below 1.0 (0.06), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Frequently Asked Questions
What is Polomar Health's annual revenue?
Polomar Health (PMHS) reported $59K in total revenue for fiscal year 2024. This represents a 40.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Polomar Health's revenue growing?
Polomar Health (PMHS) revenue grew by 40.6% year-over-year, from $42K to $59K in fiscal year 2024.
Is Polomar Health profitable?
No, Polomar Health (PMHS) reported a net income of -$1.3M in fiscal year 2024, with a net profit margin of -2280.3%.
What is Polomar Health's EBITDA?
Polomar Health (PMHS) had EBITDA of -$1.0M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Polomar Health's gross margin?
Polomar Health (PMHS) had a gross margin of 52.5% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Polomar Health's operating margin?
Polomar Health (PMHS) had an operating margin of -2209.1% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Polomar Health's net profit margin?
Polomar Health (PMHS) had a net profit margin of -2280.3% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Polomar Health's return on equity (ROE)?
Polomar Health (PMHS) has a return on equity of -15.6% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Polomar Health's free cash flow?
Polomar Health (PMHS) generated -$1.1M in free cash flow during fiscal year 2024. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Polomar Health's operating cash flow?
Polomar Health (PMHS) generated -$1.0M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Polomar Health's total assets?
Polomar Health (PMHS) had $10.0M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Polomar Health's capital expenditures?
Polomar Health (PMHS) invested $91K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
What is Polomar Health's current ratio?
Polomar Health (PMHS) had a current ratio of 0.06 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Polomar Health's debt-to-equity ratio?
Polomar Health (PMHS) had a debt-to-equity ratio of 0.16 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Polomar Health's return on assets (ROA)?
Polomar Health (PMHS) had a return on assets of -13.5% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Polomar Health's cash runway?
Based on fiscal year 2024 data, Polomar Health (PMHS) had $6K in cash against an annual operating cash burn of $1.0M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Polomar Health's Piotroski F-Score?
Polomar Health (PMHS) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Polomar Health's earnings high quality?
Polomar Health (PMHS) has an earnings quality ratio of 0.76x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Polomar Health cover its interest payments?
Polomar Health (PMHS) has an interest coverage ratio of -31.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Polomar Health?
Polomar Health (PMHS) scores 33 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.